Tag: OCUL

It’s crunch time. These 4 biotechs have what it takes to score crucial regulatory approvals Biotech stocks live and die by FDA decisions. Shares can soar or plunge depending on the FDA decision. Even an approval can spark a selloff if it’s not what investors expect. All four biotech stocks below have a fast-approaching PDUFA date. […]